391 related articles for article (PubMed ID: 2843573)
1. Effects of active vitamin D3 and parathyroid hormone on the serum osteocalcin in idiopathic hypoparathyroidism and pseudohypoparathyroidism.
Mizunashi K; Furukawa Y; Miura R; Yumita S; Sohn HE; Yoshinaga K
J Clin Invest; 1988 Sep; 82(3):861-5. PubMed ID: 2843573
[TBL] [Abstract][Full Text] [Related]
2. Sigmoidal curve shift in idiopathic hypoparathyroidism and pseudohypoparathyroidism.
Mizunashi K; Furukawa Y; Goto MM; Abe K
Calcif Tissue Int; 1998 Apr; 62(4):290-4. PubMed ID: 9504951
[TBL] [Abstract][Full Text] [Related]
3. The relationship between serum intact parathyroid hormone and calcium in idiopathic hypoparathyroidism.
Mizunashi K; Furukawa Y; Abe K; Yoshinaga K
Calcif Tissue Int; 1993 Dec; 53(6):378-83. PubMed ID: 8293350
[TBL] [Abstract][Full Text] [Related]
4. Demonstration of a lack of change in serum 1 alpha,25-dihydroxyvitamin D in response to parathyroid extract in pseudohypoparathyroidism.
Lambert PW; Hollis BW; Bell NH; Epstein S
J Clin Invest; 1980 Oct; 66(4):782-91. PubMed ID: 7419719
[TBL] [Abstract][Full Text] [Related]
5. Comparative efficacy of various vitamin D metabolites in the treatment of various types of hypoparathyroidism.
Okano K; Furukawa Y; Morii H; Fujita T
J Clin Endocrinol Metab; 1982 Aug; 55(2):238-43. PubMed ID: 6979550
[TBL] [Abstract][Full Text] [Related]
6. [Plasma vitamin D metabolites in parathyroid diseases (author's transl)].
Unakami H
Nihon Naibunpi Gakkai Zasshi; 1982 Mar; 58(3):234-47. PubMed ID: 6980145
[TBL] [Abstract][Full Text] [Related]
7. Biochemical markers of bone turnover, intact serum parathyroid horn and renal calcium excretion in patients with pseudohypoparathyroidism and hypoparathyroidism before and during vitamin D treatment.
Kruse K; Kracht U; Wohlfart K; Kruse U
Eur J Pediatr; 1989 Apr; 148(6):535-9. PubMed ID: 2744015
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor-23 is regulated by 1alpha,25-dihydroxyvitamin D.
Collins MT; Lindsay JR; Jain A; Kelly MH; Cutler CM; Weinstein LS; Liu J; Fedarko NS; Winer KK
J Bone Miner Res; 2005 Nov; 20(11):1944-50. PubMed ID: 16234967
[TBL] [Abstract][Full Text] [Related]
9. Skeletal responsiveness to parathyroid hormone in pseudohypoparathyroidism.
Kanatani M; Sugimoto T; Kaji H; Ikeda K; Chihara K
Eur J Endocrinol; 2001 Mar; 144(3):263-9. PubMed ID: 11248746
[TBL] [Abstract][Full Text] [Related]
10. Treatment of pseudohypoparathyroidism with 1 alpha-hydroxyvitamin D3.
Furukawa Y; Sohn H; Unakami H; Yumita S
Contrib Nephrol; 1980; 22():68-73. PubMed ID: 7398339
[TBL] [Abstract][Full Text] [Related]
11. Hypoparathyroidism and pseudohypoparathyroidism.
Maeda SS; Fortes EM; Oliveira UM; Borba VC; Lazaretti-Castro M
Arq Bras Endocrinol Metabol; 2006 Aug; 50(4):664-73. PubMed ID: 17117292
[TBL] [Abstract][Full Text] [Related]
12. Ratio of baseline level/maximum level of serum PTH in pseudohypoparathyroidism and primary hyperparathyroidism.
Mizunashi K; Furukawa Y; Goto MM
Calcif Tissue Int; 1998 Feb; 62(2):99-103. PubMed ID: 9437041
[TBL] [Abstract][Full Text] [Related]
13. Response of plasma 1,25-dihydroxyvitamin D in the human PTH(1-34) infusion test: an improved index for the diagnosis of idiopathic hypoparathyroidism and pseudohypoparathyroidism.
Miura R; Yumita S; Yoshinaga K; Furukawa Y
Calcif Tissue Int; 1990 May; 46(5):309-13. PubMed ID: 2159833
[TBL] [Abstract][Full Text] [Related]
14. Regulation of 1,25 (OH)2D synthesis in hypoparathyroidism and pseudohypoparathyroidism.
Breslau NA; Weinstock RS
Am J Physiol; 1988 Nov; 255(5 Pt 1):E730-6. PubMed ID: 2847540
[TBL] [Abstract][Full Text] [Related]
15. Effects of endogenous and exogenous parathyroid hormone on tubular reabsorption of calcium in pseudohypoparathyroidism.
Yamamoto M; Takuwa Y; Masuko S; Ogata E
J Clin Endocrinol Metab; 1988 Mar; 66(3):618-25. PubMed ID: 2832440
[TBL] [Abstract][Full Text] [Related]
16. [Studies on the measurement of vitamin D derivatives in human plasma. III. Plasma concentrations of vitamin D derivatives in various diseases (author's transl)].
Dokoh S; Morita R; Fukunaga M; Yamamoto I; Shigeno C; Yamamoto A; Yamada K; Torizuka K
Nihon Naibunpi Gakkai Zasshi; 1982 May; 58(5):758-70. PubMed ID: 6286379
[TBL] [Abstract][Full Text] [Related]
17. Treatment of hypocalcemia caused by hypoparathyroidism or pseudohypoparathyroidism with domestic-made calcitriol: a prospective and self-controlled clinical trial.
Wang O; Xing XP; Meng XW; Xia WB; Li M; Jiang Y; Hu YY; Liu HC
Chin Med J (Engl); 2009 Feb; 122(3):279-83. PubMed ID: 19236804
[TBL] [Abstract][Full Text] [Related]
18. Treatment of hypoparathyroidism and pseudohypoparathyroidism with metabolites of vitamin D: evidence for impaired conversion of 25-hydroxyvitamin D to 1 alpha,25-dihydroxyvitamin D.
Kooh SW; Fraser D; DeLuca HF; Holick MF; Belsey RE; Clark MB; Murray TM
N Engl J Med; 1975 Oct; 293(17):840-4. PubMed ID: 170516
[TBL] [Abstract][Full Text] [Related]
19. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
20. A patient with pseudohypoparathyroidism with increased serum calcium and 1 alpha, 25-dihydroxyvitamin D after exogenous parathyroid hormone administration.
Lawoyin S; Norman DA; Zerwekh JE; Breslau NA; Pak CY
J Clin Endocrinol Metab; 1979 Nov; 49(5):783-6. PubMed ID: 489718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
